128 related articles for article (PubMed ID: 38608144)
1. Treatment Strategy for Breast Benign Intraductal Papilloma: A Meta-Analysis.
Lou C; Wang W; Zhou B
J Environ Pathol Toxicol Oncol; 2024; 43(3):39-49. PubMed ID: 38608144
[TBL] [Abstract][Full Text] [Related]
2. Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
Zhang X; Liu W; Hai T; Li F
Ann Surg Oncol; 2021 Dec; 28(13):8643-8650. PubMed ID: 34331160
[TBL] [Abstract][Full Text] [Related]
3. Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H; Bomeisl P; Amin AL; Marshall HN; Gilmore H; Harbhajanka A
Hum Pathol; 2022 Oct; 128():90-100. PubMed ID: 35863513
[TBL] [Abstract][Full Text] [Related]
4. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
5. The Management Strategy of Benign Solitary Intraductal Papilloma on Breast Core Biopsy.
Ko D; Kang E; Park SY; Kim SM; Jang M; Yun B; Chae S; Jang Y; Kim HJ; Kim SW; Kim EK
Clin Breast Cancer; 2017 Aug; 17(5):367-372. PubMed ID: 28438672
[TBL] [Abstract][Full Text] [Related]
6. Non-mass-associated intraductal papillomas: is excision necessary?
Weisman PS; Sutton BJ; Siziopikou KP; Hansen N; Khan SA; Neuschler EI; Rohan SM; Franz JM; Sullivan ME
Hum Pathol; 2014 Mar; 45(3):583-8. PubMed ID: 24444467
[TBL] [Abstract][Full Text] [Related]
7. Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution.
Alberty-Oller JJ; Reyes S; Moshier E; Ru M; Weltz S; Santos A; Pisapati K; Port E; Jaffer S
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1481. PubMed ID: 34729946
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Risk Associated With Benign Intraductal Papillomas Initially Diagnosed on Core Needle Biopsy.
Nasehi L; Sturgis CD; Sharma N; Turk P; Calhoun BC
Clin Breast Cancer; 2018 Dec; 18(6):468-473. PubMed ID: 30017794
[TBL] [Abstract][Full Text] [Related]
9. Audit on Intraductal Papilloma of the Breast: Upgrade Rate, Management Pitfalls, and Updated Guidelines in a Tertiary Health Care Center.
Esmayil H; Abayazeed S; Hajaj M
Cureus; 2021 Oct; 13(10):e18763. PubMed ID: 34796058
[TBL] [Abstract][Full Text] [Related]
10. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy.
Rizzo M; Lund MJ; Oprea G; Schniederjan M; Wood WC; Mosunjac M
Ann Surg Oncol; 2008 Apr; 15(4):1040-7. PubMed ID: 18204989
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision.
Abbassi-Rahbar S; Sack S; Larson KE; Wagner JL; Kilgore LJ; Balanoff CR; Winblad OD; Amin AL
Ann Surg Oncol; 2021 Oct; 28(10):5768-5774. PubMed ID: 34338925
[TBL] [Abstract][Full Text] [Related]
12. Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.
Pareja F; Corben AD; Brennan SB; Murray MP; Bowser ZL; Jakate K; Sebastiano C; Morrow M; Morris EA; Brogi E
Cancer; 2016 Sep; 122(18):2819-27. PubMed ID: 27315013
[TBL] [Abstract][Full Text] [Related]
13. Intraductal Papilloma Without Atypia on Image- Guided Breast Biopsy: Upgrade Rates to Carcinoma at Surgical Excision.
Leithner D; Kaltenbach B; Hödl P; Möbus V; Brandenbusch V; Falk S; Park C; Vogl TJ; Müller-Schimpfle M
Breast Care (Basel); 2018 Oct; 13(5):364-368. PubMed ID: 30498423
[TBL] [Abstract][Full Text] [Related]
14. Papillary Breast Lesions: Association with Malignancy and Upgrade Rates on Surgical Excision.
Tran HT; Mursleen A; Mirpour S; Ghanem O; Farha MJ
Am Surg; 2017 Nov; 83(11):1294-1297. PubMed ID: 29183534
[TBL] [Abstract][Full Text] [Related]
15. Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.
Genco IS; Tugertimur B; Manolas PA; Hasanovic A; Hajiyeva S
Am J Surg; 2020 Sep; 220(3):677-681. PubMed ID: 32007236
[TBL] [Abstract][Full Text] [Related]
16. Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
Keating N; Cevik J; Hopkins D; Lippey J
J Surg Oncol; 2024 May; 129(6):1025-1033. PubMed ID: 38305061
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
[TBL] [Abstract][Full Text] [Related]
18. Should we excise? Are there any clinical or histologic features that predict upgrade in papillomas, incidental or non-incidental?
Zaleski M; Chen YA; Chetlen AL; Mack J; Xu L; Dodge DG; Karamchandani DM
Ann Diagn Pathol; 2018 Aug; 35():62-68. PubMed ID: 29793212
[TBL] [Abstract][Full Text] [Related]
19. Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision.
MacColl C; Salehi A; Parpia S; Hodgson N; Ramonas M; Williams P
Virchows Arch; 2019 Dec; 475(6):701-707. PubMed ID: 31372738
[TBL] [Abstract][Full Text] [Related]
20. Papilloma diagnosed on core biopsies has a low upgrade rate.
Li X; Aho M; Newell MS; Clifford K; Patel JG; Jou S; Cohen MA
Clin Imaging; 2020 Mar; 60(1):67-74. PubMed ID: 31864203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
